Freebird Partners LP 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 2:14 pm Purchase |
2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 414,102 9.900% |
71,656 (+20.92%) |
Filing |
| 2025-01-28 5:31 pm Purchase |
2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 342,446 9.990% |
272,214 (+387.59%) |
Filing |
| 2023-07-20 7:52 pm Purchase |
2023-07-14 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 70,232 19.990% |
23,732 (+51.04%) |
Filing |
| 2023-04-04 5:14 pm Purchase |
2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 46,501 12.600% |
28,329 (+155.89%) |
Filing |
| 2022-12-02 5:01 pm Purchase |
2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 18,172 5.300% |
18,172 (New Position) |
Filing |